Clinical impact of whole body FDG-PET for recurrent biliary cancer: A multicenter study

Kazuhiro Kitajima, Koji Murakami, Kakuko Kanegae, Nagara Tamaki, Tomohiro Kaneta, Hiroshi Fukuda, Kotaro Nakajima, Hirofumi Fujii, Ukihide Tateishi, Kazuo Kubota, Tsuyoshi Suga, Yuji Nakamoto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To evaluate the clinical usefulness of positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) in patients with follow-up or suspected recurrent biliary cancer in a multicenter study. Methods: We performed a retrospective review of 50 patients who underwent FDG-PET (either integrated PET/CT or manual fusion of dedicated PET and CT) scans for post-treatment surveillance of biliary cancer. Recurrence was suspected in 40 of these patients on the basis of tumor marker levels, and/or findings of conventional imaging (group A). Clinical findings in the remaining 10 patients showed them to be disease-free (group B). The diagnostic performance and clinical impact of PET were analyzed. Results: Recurrence was confirmed in 28 out of the 40 patients in group A, and 1 of the 10 patients in group B. Patient-based analysis showed that the sensitivity, specificity, and accuracy of PET for detecting recurrence were 86% (25/29), 91% (19/21), and 88% (44/50), respectively. The one patient with recurrence in group B was correctly interpreted by PET. Positive test likelihood ratio and negative test likelihood ratio were increased from 1.69 to 9.05, and 0.08 to 0.32, respectively, after PET study. The findings of PET resulted in a change of management for 10 out of the 50 patients (20%) by initiating an unplanned treatment strategy (n = 7), by obviating the need for planned diagnostic procedures (n = 2), or by changing the treatment plan (n = 1). Conclusion: FDG-PET/CT or PET with CT yielded helpful information in patients with suspected recurrent biliary cancer.

Original languageEnglish
Pages (from-to)709-715
Number of pages7
JournalAnnals of Nuclear Medicine
Volume23
Issue number8
DOIs
Publication statusPublished - 2009 Oct

Keywords

  • Biliary cancer
  • F-FDG
  • PET
  • PET/CT
  • Recurrence

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Clinical impact of whole body FDG-PET for recurrent biliary cancer: A multicenter study'. Together they form a unique fingerprint.

  • Cite this

    Kitajima, K., Murakami, K., Kanegae, K., Tamaki, N., Kaneta, T., Fukuda, H., Nakajima, K., Fujii, H., Tateishi, U., Kubota, K., Suga, T., & Nakamoto, Y. (2009). Clinical impact of whole body FDG-PET for recurrent biliary cancer: A multicenter study. Annals of Nuclear Medicine, 23(8), 709-715. https://doi.org/10.1007/s12149-009-0297-6